Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of oral panobinostat plus subcutaneous bortezomib and oral dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma (PANORAMA 3): an open-label, randomised, phase 2 study.
Laubach JP, Schjesvold F, Mariz M, Dimopoulos MA, Lech-Maranda E, Spicka I, Hungria VTM, Shelekhova T, Abdo A, Jacobasch L, Polprasert C, Hájek R, Illés Á, Wróbel T, Sureda A, Beksac M, Gonçalves IZ, Bladé J, Rajkumar SV, Chari A, Lonial S, Spencer A, Maison-Blanche P, Moreau P, San-Miguel JF, Richardson PG. Laubach JP, et al. Among authors: mariz m. Lancet Oncol. 2021 Jan;22(1):142-154. doi: 10.1016/S1470-2045(20)30680-X. Epub 2020 Dec 7. Lancet Oncol. 2021. PMID: 33301738 Clinical Trial.
Immune status of high-risk smoldering multiple myeloma patients and its therapeutic modulation under LenDex: a longitudinal analysis.
Paiva B, Mateos MV, Sanchez-Abarca LI, Puig N, Vidriales MB, López-Corral L, Corchete LA, Hernandez MT, Bargay J, de Arriba F, de la Rubia J, Teruel AI, Giraldo P, Rosiñol L, Prosper F, Oriol A, Hernández J, Esteves G, Lahuerta JJ, Bladé J, Perez-Simon JA, San Miguel JF; Spanish Myeloma Group / Program Study and Treatment of Hematological Malignancies cooperative study groups. Paiva B, et al. Blood. 2016 Mar 3;127(9):1151-62. doi: 10.1182/blood-2015-10-662320. Epub 2015 Dec 14. Blood. 2016. PMID: 26668134 Free article. Clinical Trial.
Recommendations from a Portuguese Expert Group for Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Patients in Clinical Practice.
Almeida A, Pierdomenico F, Guerrero BP, Saraiva F, Montalvão A, Coutinho J, Mariz M, Melo T, Santos MJ, Pereira A, Cerveira N. Almeida A, et al. Among authors: mariz m. Acta Med Port. 2019 Aug 1;32(7-8):550-557. doi: 10.20344/amp.11823. Epub 2019 Aug 1. Acta Med Port. 2019. PMID: 31445538 Free article.
Therapeutic Leukapheresis: Experience of a Single Oncologic Centre.
Rosales M, Roncon S, Mariz M, Ferreira AM, Faria F, Santos L. Rosales M, et al. Among authors: mariz m. Transfus Med Hemother. 2022 Feb 1;49(4):250-257. doi: 10.1159/000520933. eCollection 2022 Aug. Transfus Med Hemother. 2022. PMID: 36159955 Free PMC article.
Myeloid Disease with the CSF3R T618I Mutation after CLL.
Couto ME, Bizarro S, Sousa D, Domingues N, Oliveira I, Martins G, Teixeira MR, Mariz M. Couto ME, et al. Among authors: mariz m. Case Rep Hematol. 2020 Dec 21;2020:6670965. doi: 10.1155/2020/6670965. eCollection 2020. Case Rep Hematol. 2020. PMID: 33414971 Free PMC article.
16 results